Navigation Links
Neuro-Biotech Corp. Neuroceuticals® : A solution to feed the brain
Date:11/10/2010

Neuro-Biotech Corp. Neuroceuticals® : A solution to feed the brain


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, New Products & Services Click to view news release full screen  

Neuro-Biotech Corp. Neuroceuticals® : A solution to feed the brain

 

BASEL, Switzerland, Nov. 10 /PRNewswire/ - Neuro-Biotech Corporation (PINKSHEET: MRES) (OTCQB: MRES)

Neuro-Biotech Corp. is currently actively working towards the commercialization of natural products called "Neuroceuticals®", that are specially designed to restore the nervous system equilibrium and improve the state of health as well as the quality of life of people affected by stress-related disorders.

Our "Neuroceuticals®" respect international established quality standards (USP, EP and JP) in regards with purity, strength, and consistency of the products for human consumption.

According with our licences, we have a portfolio of four (4) innovative and selective products.

  • Neuro-Relax®
    A protein based supplement that favours the sleep's quality, decreases the anxiety and nervous pressure, improves general anxiety, anxious disorders, physical, emotional and mental stress and has a tranquilizing and soothing effect
  • Neuro-Learn®
    An adaptogene that helps stimulating the noradregenic and cholinergic systems resulting in improvement with memory, depression, concentration, attention and vigilance in particular with children suffering from attention deficit disorder which often need treatment with methylphenidate, among others marketed under the name of Ritalin®.
  • Neuro-Stim®
    An adoptogene which effect results in an increase in energy in order to reduce the effects of depression, hypoglycaemia, stress, obesity and type II diabetes as well as food behaviour's disorders such as bulimia.
  • Neuro-Lean®
    A product specially conceived to help with weight-loss management, optimizing the energetic spending as well as maintaining body weight.
  • Those four (4) products will be sold and distributed by many means; directly from us under our own label as well as through "Private labels" such as pharmacies, megastore and natural products brands. Since we are actively in a negotiation process, it will be the distributor's mandate, in terms of their respective part of the market, to target the clientele they believe should be reached.

    For more detailed information on the scientific data and the Neuroceuticals®, we invite you to consult our website at neuro-biotechcorp.com under the products section.

    Neuro-Biotech is currently negotiating with 2 separates groups on the East coast and West coast for them to distribute the Neuroceuticals®. Management also decided that in order to maximize the market penetration and based on the product composition, it was it the Company's best interest to categorize the Neuroceuticals® as Natural Products and Food Supplements.

    For more information, do not hesitate to contact us by using the contact form on our corporate website at neuro-biotechcorp.com. Your request will be transferred to the appropriate persons and we will get back to you as soon as possible.


    '/>"/>
    SOURCE Neuro-Biotech Corp.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related biology technology :

    1. Mr Claude Poulin nominated as President and CEO of Neuro-Biotech Corp.
    2. Neuro-Biotechs Solution for a Doctor near You: Early Detection for Alzheimers and Chronic Fatigue Syndrome!
    3. NEURO-BIOTECH DISCLOSES ITS LIST OF LICENSES
    4. NEURO-BIOTECH CORPORATION: Updates and latest developments
    5. BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
    6. InstaCare Corp. Continues Turnaround & Reports 291% Revenues Increase in 2Q 2008
    7. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal 2008 on September 9, 2008
    8. BioSpecifics Technologies Corp. Buys Down Royalties for Peyronies Disease
    9. Aegis Analytical Corp. Showcases Discoverant at Inaugural Venture Capital in the Rockies Fall
    10. BioElectronics Corp. Announces $400,000 in New Orders From the Middle East
    11. BioSpecifics Technologies Corp. Announces Appointment of Dr. Matthew Geller to Board of Directors
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/21/2017)... , ... February 21, 2017 , ... ... transformative design and manufacturing solutions for original equipment manufacturers (OEMs) , today announced ... marks Creation Technologies’ third consecutive year winning in its category of electronics manufacturing ...
    (Date:2/21/2017)... 2017 Scientists From Two Companies ... Plastic Industry  ... STEER, creator of advanced materials platform ... fields of plastics, pharmaceuticals, food and nutraceuticals, biomaterials and biorefining, ... science & technology company, on creating co-rotating twin screw ...
    (Date:2/20/2017)... BIOA ) announced today that Jean-Francois Huc ... COO, has been named President, effective immediately.  In ... overseen the construction, start-up and operation of the manufacturing plant in ... JV.  Fabrice has also been extensively involved in the negotiations with ... ...
    (Date:2/20/2017)... ... February 20, 2017 , ... Cancer ... “Crosswalk Insight: Oncology™” (Crosswalk), a unique precision medicine knowledge visualization and decision support ... accessed through Inspirata’s diagnostic cockpit and is downloadable as an app for any ...
    Breaking Biology Technology:
    (Date:2/21/2017)... LONDON , February 21, 2017 ... um 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr ... es einige Hindernisse zu überwinden gilt, um diese Prognose ... ... unter anderem die Mobilisierung der finanziellen Mittel für die ...
    (Date:2/14/2017)...  Wake Forest Baptist Medical Center today announced Julie Ann ... officer (CEO). Freischlag joins the medical center on May ... M.D., who last year announced that he would transition ... leading it since 2008.   As CEO, ... Baptist,s academic health system, which includes Wake Forest School ...
    (Date:2/13/2017)... WASHINGTON , Feb. 13, 2017 Former ... U.S. Senate Judiciary Committee, Janice Kephart of ... regarding President Donald Trump,s "Executive Order: Protecting ... States" (Jan. 27, 2017):  "As President Trump,s ... 9th Circuit has now essentially banned the travel ban, ...
    Breaking Biology News(10 mins):